These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7555975)

  • 1. Pharmacokinetics of tiagabine, a gamma-aminobutyric acid-uptake inhibitor, in healthy subjects after single and multiple doses.
    Gustavson LE; Mengel HB
    Epilepsia; 1995 Jun; 36(6):605-11. PubMed ID: 7555975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of renal impairment on the pharmacokinetics and tolerability of tiagabine.
    Cato A; Gustavson LE; Qian J; El-Shourbagy T; Kelly EA
    Epilepsia; 1998 Jan; 39(1):43-7. PubMed ID: 9578011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor.
    Suzdak PD; Jansen JA
    Epilepsia; 1995 Jun; 36(6):612-26. PubMed ID: 7555976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiagabine pharmacology in profile.
    Brodie MJ
    Epilepsia; 1995; 36 Suppl 6():S7-S9. PubMed ID: 8595791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and safety of tiagabine in subjects with various degrees of hepatic function.
    Lau AH; Gustavson LE; Sperelakis R; Lam NP; El-Shourbagy T; Qian JX; Layden T
    Epilepsia; 1997 Apr; 38(4):445-51. PubMed ID: 9118850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population analysis of the pharmacokinetics of tiagabine in patients with epilepsy.
    Samara EE; Gustavson LE; El-Shourbagy T; Locke C; Granneman GR; Sommerville KW
    Epilepsia; 1998 Aug; 39(8):868-73. PubMed ID: 9701378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy.
    Morimoto K; Sato H; Yamamoto Y; Watanabe T; Suwaki H
    Epilepsia; 1997 Sep; 38(9):966-74. PubMed ID: 9579934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic analysis of the interaction between tiagabine and midazolam with an allosteric model that incorporates signal transduction.
    Jonker DM; Vermeij DA; Edelbroek PM; Voskuyl RA; Piotrovsky VK; Danhof M
    Epilepsia; 2003 Mar; 44(3):329-38. PubMed ID: 12614388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice.
    Łuszczki J; Swiader M; Czuczwar M; Kiś J; Czuczwar SJ
    Pharmacol Biochem Behav; 2003 May; 75(2):319-27. PubMed ID: 12873622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugs.
    So EL; Wolff D; Graves NM; Leppik IE; Cascino GD; Pixton GC; Gustavson LE
    Epilepsy Res; 1995 Nov; 22(3):221-6. PubMed ID: 8991789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiagabine.
    Schachter SC
    Epilepsia; 1999; 40 Suppl 5():S17-22. PubMed ID: 10530690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of interaction between tiagabine, a new antiepileptic drug, and the benzodiazepine triazolam.
    Richens A; Marshall RW; Dirach J; Jansen JA; Snel S; Pedersen PC
    Drug Metabol Drug Interact; 1998; 14(3):159-77. PubMed ID: 10366992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiagabine monotherapy in the treatment of partial epilepsy.
    Schachter SC
    Epilepsia; 1995; 36 Suppl 6():S2-S6. PubMed ID: 8595789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical implications of pharmacology and pharmacokinetics of tiagabine].
    Pita-Calandre E
    Rev Neurol; 1999 Feb 1-15; 28(3):337-9. PubMed ID: 10714305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic modelling of tiagabine CNS effects upon chronic treatment in rats: lack of change in concentration-EEG effect relationship.
    Cleton A; Altorf BA; Voskuyl RA; Danhof M
    Eur J Pharm Sci; 2000 Dec; 12(2):141-50. PubMed ID: 11102742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tiagabine: recent findings and recommendations for dosage].
    Herranz JL
    Rev Neurol; 1998 Jul; 27(155):101-3. PubMed ID: 9674039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiagabine.
    Mengel H
    Epilepsia; 1994; 35 Suppl 5():S81-4. PubMed ID: 8039477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tiagabine and vigabatrin on GABA uptake into primary cultures of rat cortical astrocytes.
    Leach JP; Sills GJ; Majid A; Butler E; Carswell A; Thompson GG; Brodie MJ
    Seizure; 1996 Sep; 5(3):229-34. PubMed ID: 8902926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy.
    Adkins JC; Noble S
    Drugs; 1998 Mar; 55(3):437-60. PubMed ID: 9530548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of tiagabine in healthy elderly volunteers and elderly patients with epilepsy.
    Snel S; Jansen JA; Mengel HB; Richens A; Larsen S
    J Clin Pharmacol; 1997 Nov; 37(11):1015-20. PubMed ID: 9505994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.